Do VHL and HIF-1 mirror p53 and Mdm-2? Degradation-transactivation loops of oncoproteins and tumor suppressors

被引:28
作者
Blagosklonny, MV [1 ]
机构
[1] NCI, Med Branch, NIH, Bethesda, MD 20892 USA
关键词
p53; VHL; HIF-1; alpha; mdm-2; beta-catenin;
D O I
10.1038/sj.onc.1204055
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recently it has been shown that the VHL tumor suppressor targets the hypoxia-inducible transcription factor (HIF-1) for ubiquitin-dependent degradation by the proteasome, Past mysteries of the p53 tumor suppressor help to solve the present puzzles of the VHL tumor suppressor. Thus, Mdm-2 targets the p53 tumor suppressor for ubiquitin-dependent degradation by the proteasome, but, in addition, the p53 transcription factor induces Mdm-2, thus, establishing a feedback loop. Hypoxia or DNA damage by abrogating binding of HIF-1 with VHL and p53 with Mdm-2, respectively, leads to stabilization and accumulation transcriptionally active HIF-1 and p53, More detailed analysis depicts the VHL/HIF-1 pair as the p53/mdm-2 pair that is turned upside down, suggesting that VHL may be a HIF-1-inducible gene of the feedback loop. The extended model proposes that an oncoprotein and a tumor suppressor due to transactivation coupled with feedback protein degradation might form functional pairs (Rb/E7, E2F/Rb, E2F/Mdm-2, catenin/APC, p27, cyclin D1, Rb/gankyrin), thus, predicting missing links.
引用
收藏
页码:395 / 398
页数:4
相关论文
共 37 条
  • [1] Inhibitors of transcription, proteasome inhibitors, and DNA-damaging drugs differentially affect feedback of p53 degradation
    An, WG
    Chuman, Y
    Fojo, T
    Blagosklonny, MV
    [J]. EXPERIMENTAL CELL RESEARCH, 1998, 244 (01) : 54 - 60
  • [2] Regulation of BRCA1 by protein degradation
    Blagosklonny, MV
    An, WG
    Melillo, G
    Nguyen, P
    Trepel, JB
    Neckers, LM
    [J]. ONCOGENE, 1999, 18 (47) : 6460 - 6468
  • [3] Loss of function and p53 protein stabilization
    Blagosklonny, MV
    [J]. ONCOGENE, 1997, 15 (16) : 1889 - 1893
  • [4] DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation
    Blattner, C
    Tobiasch, E
    Litfen, M
    Rahmsdorf, HJ
    Herrlich, P
    [J]. ONCOGENE, 1999, 18 (09) : 1723 - 1732
  • [5] Blattner C, 1999, MOL CELL BIOL, V19, P3704
  • [6] Regulation of E2F through ubiquitin-proteasome-dependent degradation: Stabilization by the pRB tumor suppressor protein
    Campanero, MR
    Flemington, EK
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) : 2221 - 2226
  • [7] Excess β-catenin promotes accumulation of transcriptionally active p53
    Damalas, A
    Ben-Ze'ev, A
    Simcha, I
    Shtutman, N
    Leal, JFN
    Zhurinsky, J
    Geiger, B
    Oren, M
    [J]. EMBO JOURNAL, 1999, 18 (11) : 3054 - 3063
  • [8] INHIBITION OF TRANSCRIPTION ELONGATION BY THE VHL TUMOR-SUPPRESSOR PROTEIN
    DUAN, DR
    PAUSE, A
    BURGESS, WH
    ASO, T
    CHEN, DYT
    GARRETT, KP
    CONAWAY, RC
    CONAWAY, JW
    LINEHAN, WM
    KLAUSNER, RD
    [J]. SCIENCE, 1995, 269 (5229) : 1402 - 1406
  • [9] The complexity of p53 modulation: emerging patterns from divergent signals
    Giaccia, AJ
    Kastan, MB
    [J]. GENES & DEVELOPMENT, 1998, 12 (19) : 2973 - 2983
  • [10] The hypoxic response: Huffing and HIFing
    Guillemin, K
    Krasnow, MA
    [J]. CELL, 1997, 89 (01) : 9 - 12